Table 2.
EQ-5D-5L frequencies and proportions reported by dimension and level
| Total n (%) | BC patients n (%) | BC survivors n (%) | p-value* | |
|---|---|---|---|---|
| Mobility | ||||
| No problems | 221 (71.5) | 65 (60.7) | 156 (77.2) | 0.014 |
| Slight problems | 65 (21.0) | 30 (28.0) | 35 (17.3) | |
| Moderate problems | 12 (3.9) | 8 (7.5) | 4 (2.0) | |
| Severe problems | 10 (3.2) | 4 (3.7) | 6 (3.0) | |
| Unable/extreme problems | 1 (0.3) | 0 (0.0) | 1 (0.5) | |
| Self-care | ||||
| No problems | 255 (82.5) | 74 (69.2) | 181 (89.6) | < 0.001 |
| Slight problems | 36 (11.7) | 18 (16.8) | 18 (8.9) | |
| Moderate problems | 11 (3.6) | 9 (8.4) | 2 (1.0) | |
| Severe problems | 7 (2.3) | 6 (5.6) | 1 (0.5) | |
| Usual activities | ||||
| No problems | 209 (67.6) | 64 (59.8) | 145 (71.8) | 0.002 |
| Slight problems | 83 (26.9) | 30 (28.0) | 53 (26.2) | |
| Moderate problems | 10 (3.2) | 8 (7.5) | 2 (1.0) | |
| Severe problems | 6 (1.9) | 5 (4.7) | 1 (0.5) | |
| Unable/extreme problems | 1 (0.3) | 0 (0.0) | 1 (0.5) | |
| Pain/discomfort | ||||
| No problems | 76 (24.6) | 22 (20.6) | 54 (26.7) | NS |
| Slight problems | 170 (55.0) | 54 (50.5) | 116 (57.4) | |
| Moderate problems | 40 (12.9) | 19 (17.8) | 21 (10.4) | |
| Severe problems | 19 (6.1) | 8 (7.5) | 11 (5.4) | |
| Unable/extreme problems | 4 (1.3) | 4 (3.7) | 0 (0.0) | |
| Anxiety/depression | ||||
| No problems | 132 (42.7) | 32 (29.9) | 100 (49.5) | < 0.001 |
| Slight problems | 116 (37.5) | 37 (34.6) | 79 (39.1) | |
| Moderate problems | 27 (8.7) | 14 (13.1) | 13 (6.4) | |
| Severe problems | 26 (8.4) | 17 (15.9) | 9 (4.5) | |
| Unable/extreme problems | 8 (2.6) | 7 (6.5) | 1 (0.5) | |
BC breast cancer, NS not significant
*Results of χ2 tests compared between groups of patients and survivors (this was before matching with peers from the general population)